SA
TRAX logo
First Tracks Biotherapeutics Inc(TRAX)
Closing price · checked 4:14 PM ETAbout this dataData status
$41.64▼-2.82 (-6.34%)
Extended:$41.64+0.00 (+0.00%)· 4:14 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

First Tracks Biotherapeutics Inc (TRAX)

Total Non-Current Liabilities

$1.36M

Quarterly · Period ending: · USD

TRAX logo

TRAX Total Non-Current Liabilities

Latest reported$12.03M
TRAX FY Total Non-Current Liabilities ($16.04M → $12.03M)
Powered by
High-resolution chart · PNG

What is total non-current liabilities?

Long-term obligations due beyond one year.

TRAX total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

First Tracks Biotherapeutics Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)Change
12,032,000−14.74%
14,112,000−12.00%
16,037,000—

Frequently asked questions: TRAX total non-current liabilities

What is First Tracks Biotherapeutics Inc (TRAX)'s current total non-current liabilities?

First Tracks Biotherapeutics Inc (TRAX)'s latest reported total non-current liabilities (Quarterly) is $1.36M as of Sep 30, 2026. Long-term obligations due beyond one year.

How much historical total non-current liabilities data is available for TRAX?

Stock Alarm Pro provides 3 dated annual fiscal periods observations for First Tracks Biotherapeutics Inc (TRAX)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare TRAX's total non-current liabilities to peers or set an alert?

You can open TRAX's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on TRAX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.